🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as docetaxel and carboplatin, w...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2009-02
Trial ID
NCT00820872
Treatments Being Tested
The purpose of this study is to determine if the combination of CPG 7909 an...
Status
Completed
Location
Univ. of Connecticut Health Center
Start Date
2001-10
Trial ID
NCT00031278
Treatments Being Tested
Paclitaxel 30 mg/m2 twice/week Trastuzumab 4mg/kg, loading dose, then 2 mg/...
Status
Terminated
Location
Weill Medical College of Cornell University
Start Date
2002-06
Trial ID
NCT02297230
Treatments Being Tested
StrataPATH™ is a non-randomized, open-label trial designed to explore effic...
Status
Terminated
Location
Florida Cancer Specialists - North
Start Date
2022-04-29
Trial ID
NCT05097599
To determine the safety and efficacy of CPG 7909 Injection given with Herce...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2002-09
Trial ID
NCT00043394
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2005-09-27
Trial ID
NCT00295893
Treatments Being Tested
Researchers are looking for other ways to treat breast cancer (BC) that is ...
Status
Recruiting
Location
Southern Cancer Center (SCC) ( Site 8000)
Start Date
2025-07-21
Trial ID
NCT07060807
The primary aim of this dose-finding study is to determine the maximum tole...
Status
Completed
Location
Aalborg University Hospital
Start Date
2011-03
Trial ID
NCT01295086
Treatments Being Tested
The main purpose of this research study is to find out if de-escalation of ...
Status
Withdrawn
Location
University of Rochester Medical Center
Start Date
2025-08-11
Trial ID
NCT04419181
Treatments Being Tested
This is a phase IIb, randomized, parallel-group, noncomparative, multicente...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-08
Trial ID
NCT00365365